BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scagnolari C, Antonelli G. Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome. Cytokine Growth Factor Rev 2018;40:19-31. [PMID: 29576284 DOI: 10.1016/j.cytogfr.2018.03.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Bertram KM, Tong O, Royle C, Turville SG, Nasr N, Cunningham AL, Harman AN. Manipulation of Mononuclear Phagocytes by HIV: Implications for Early Transmission Events. Front Immunol 2019;10:2263. [PMID: 31616434 DOI: 10.3389/fimmu.2019.02263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Mudla A, Jiang Y, Arimoto KI, Xu B, Rajesh A, Ryan AP, Wang W, Daugherty MD, Zhang DE, Hao N. Cell-cycle-gated feedback control mediates desensitization to interferon stimulation. Elife 2020;9:e58825. [PMID: 32945770 DOI: 10.7554/eLife.58825] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Giron LB, Colomb F, Papasavvas E, Azzoni L, Yin X, Fair M, Anzurez A, Damra M, Mounzer K, Kostman JR, Tebas P, O'Doherty U, Tateno H, Liu Q, Betts MR, Montaner LJ, Abdel-Mohsen M. Interferon-α alters host glycosylation machinery during treated HIV infection. EBioMedicine 2020;59:102945. [PMID: 32827942 DOI: 10.1016/j.ebiom.2020.102945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Soto JA, Gálvez NMS, Andrade CA, Pacheco GA, Bohmwald K, Berrios RV, Bueno SM, Kalergis AM. The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses. Front Immunol 2020;11:1513. [PMID: 32765522 DOI: 10.3389/fimmu.2020.01513] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
5 Clementi N, Ferrarese R, Criscuolo E, Diotti RA, Castelli M, Scagnolari C, Burioni R, Antonelli G, Clementi M, Mancini N. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection. J Infect Dis 2020;222:722-5. [PMID: 32559285 DOI: 10.1093/infdis/jiaa350] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 18.0] [Reference Citation Analysis]
6 Pinacchio C, Scagnolari C, Iebba V, Santinelli L, Innocenti GP, Frasca F, Bitossi C, Scordio M, Oliveto G, Ceccarelli G, Antonelli G, Mastroianni CM, d'Ettorre G. High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients. AIDS 2020;34:1467-73. [PMID: 32675560 DOI: 10.1097/QAD.0000000000002574] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
7 Antonelli G, Turriziani O, Pierangeli A, d'Ettorre G, Galardo G, Pugliese F, Mastroianni CM, Scagnolari C. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients. J Clin Virol 2020;128:104450. [PMID: 32464309 DOI: 10.1016/j.jcv.2020.104450] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Statzu M, Santinelli L, Viscido A, Pinacchio C, Ceccarelli G, Rotondo C, Corano Scheri G, Mezzaroma I, Turriziani O, Antonelli G, d'Ettorre G, Scagnolari C. Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients. Med Microbiol Immunol 2019;208:679-91. [PMID: 30564919 DOI: 10.1007/s00430-018-0574-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Subbian S. The Abstruse Side of Type I Interferon Immunotherapy for COVID-19 Cases with Comorbidities. JoR 2021;1:49-59. [DOI: 10.3390/jor1010005] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Fernandes N, Pulliam L. Inflammatory Mechanisms and Cascades Contributing to Neurocognitive Impairment in HIV/AIDS. Curr Top Behav Neurosci 2019. [PMID: 31385260 DOI: 10.1007/7854_2019_100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Santinelli L, Statzu M, Pierangeli A, Frasca F, Bressan A, Pinacchio C, Nonne C, Turriziani O, Antonelli G, d'Ettorre G, Scagnolari C. Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients. Cytokine 2019;120:273-81. [PMID: 30910260 DOI: 10.1016/j.cyto.2019.01.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang Y, Qian G, Zhu L, Zhao Z, Liu Y, Han W, Zhang X, Zhang Y, Xiong T, Zeng H, Yu X, Yu X, Zhang X, Xu J, Zou Q, Yan D. HIV-1 Vif suppresses antiviral immunity by targeting STING. Cell Mol Immunol 2021. [PMID: 34811497 DOI: 10.1038/s41423-021-00802-9] [Reference Citation Analysis]
13 Dillon SM, Wilson CC. Gut Innate Immunity and HIV Pathogenesis. Curr HIV/AIDS Rep 2021;18:128-38. [PMID: 33687703 DOI: 10.1007/s11904-021-00544-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Ceccarelli G, Statzu M, Santinelli L, Pinacchio C, Bitossi C, Cavallari EN, Vullo V, Scagnolari C, d'Ettorre G. Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS. Expert Opin Biol Ther 2019;19:949-65. [PMID: 31260331 DOI: 10.1080/14712598.2019.1638907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
15 Joshi A, Punke EB, Mehmetoglu-Gurbuz T, Peralta DP, Garg H. TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients. BMC Infect Dis 2019;19:56. [PMID: 30651082 DOI: 10.1186/s12879-019-3697-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
16 Ouyang H, Zhou Z, Zheng Q, Zhang J. Analyzing Functional Pathways and constructing gene-gene network for Narcolepsy based on candidate genes. Int J Med Sci 2020;17:1508-14. [PMID: 32669953 DOI: 10.7150/ijms.41812] [Reference Citation Analysis]
17 Santinelli L, De Girolamo G, Borrazzo C, Vassalini P, Pinacchio C, Cavallari EN, Statzu M, Frasca F, Scordio M, Bitossi C, Viscido A, Ceccarelli G, Mancone M, Mastroianni CM, Antonelli G, d'Ettorre G, Scagnolari C. Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients. J Med Virol 2021;93:4930-8. [PMID: 33913525 DOI: 10.1002/jmv.27028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 d'Ettorre G, Recchia G, Ridolfi M, Siccardi G, Pinacchio C, Innocenti GP, Santinelli L, Frasca F, Bitossi C, Ceccarelli G, Borrazzo C, Antonelli G, Scagnolari C, Mastroianni CM. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report. Medicine (Baltimore) 2020;99:e21803. [PMID: 32899009 DOI: 10.1097/MD.0000000000021803] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]